Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-Resistant Prostate Cancer × onvansertib × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Inflammatory Breast Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

enzalutamide 3 Docetaxel 3 abiraterone 2 Prednisone 2 Abiraterone Acetate 2 relugolix 1 pembrolizumab 1 olaparib 1 lenvatinib 1 inavolisib 1 belzutifan 1 apalutamide 1 PF06821497 1 Methylprednisolone 1 Lutetium-177 1 Lutetium 1 Gonadotropin-Releasing Hormone 1 Etoposide 1 Diagnostic Tests, Routine 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡